Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gao, F. G.
Right arrow Articles by Fernando, G. J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gao, F. G.
Right arrow Articles by Fernando, G. J. P.
[Cancer Research 62, 6438-6441, November 15, 2002]
© 2002 American Association for Cancer Research

Advances in Brief

Antigen-specific CD4+ T-Cell Help Is Required to Activate a Memory CD8+ T Cell to a Fully Functional Tumor Killer Cell1

Feng Guang Gao, Vithagna Khammanivong, Wen Jun Liu, Graham R. Leggatt, Ian H. Frazer and Germain J. P. Fernando2

Centre for Immunology and Cancer Research, University of Queensland, Princess Alexandra Hospital, Brisbane, QLD 4102, Australia

Although the importance of CD4+ T-cell help for generation of an effective CD8+ effector cytotoxic T cell (CTL) response is well established, the role of T-cell help in the activation of memory T cells to become fully functional tumor killer cells is undefined. Using synthetic peptide immunizations corresponding to the major CTLs and T-helper epitopes of ovalbumin, adoptive transfers of ovalbumin-specific memory CTLs (mCTLs), and ovalbumin as the tumor-specific antigen in a mouse tumor model, we have determined that T help is essential for the activation of mCTLs to kill tumors. Our data show that T-helper cells specific for the tumor-associated antigen are required for the reactivation of mCTLs by antigen presented indirectly from tumor. In contrast, effector CTLs do not need T help to kill tumors. These results have implications for induction of tumor immunotherapy by immunization.




This article has been cited by other articles:


Home page
 BloodHome page
P. Muranski, A. Boni, P. A. Antony, L. Cassard, K. R. Irvine, A. Kaiser, C. M. Paulos, D. C. Palmer, C. E. Touloukian, K. Ptak, et al.
Tumor-specific Th17-polarized cells eradicate large established melanoma
Blood, July 15, 2008; 112(2): 362 - 373.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. G. Gao, D. F. Wan, and J. R. Gu
Ex vivo Nicotine Stimulation Augments the Efficacy of Therapeutic Bone Marrow-Derived Dendritic Cell Vaccination
Clin. Cancer Res., June 15, 2007; 13(12): 3706 - 3712.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
Y. Zhang, D. Wakita, K. Chamoto, Y. Narita, N. Matsubara, H. Kitamura, and T. Nishimura
Th1 cell adjuvant therapy combined with tumor vaccination: a novel strategy for promoting CTL responses while avoiding the accumulation of Tregs
Int. Immunol., February 1, 2007; 19(2): 151 - 161.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Ayaru, S. P. Pereira, A. Alisa, A. A. Pathan, R. Williams, B. Davidson, A. K. Burroughs, T. Meyer, and S. Behboudi
Unmasking of {alpha}-Fetoprotein-Specific CD4+ T Cell Responses in Hepatocellular Carcinoma Patients Undergoing Embolization
J. Immunol., February 1, 2007; 178(3): 1914 - 1922.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M. Shi, S. Hao, T. Chan, and J. Xiang
CD4+ T cells stimulate memory CD8+ T cell expansion via acquired pMHC I complexes and costimulatory molecules, and IL-2 secretion
J. Leukoc. Biol., December 1, 2006; 80(6): 1354 - 1363.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. A. Thompson, S. K. Dissanayake, B. R. Ksander, K. L. Knutson, M. L. Disis, and S. Ostrand-Rosenberg
Tumor Cells Transduced with the MHC Class II Transactivator and CD80 Activate Tumor-Specific CD4+ T Cells Whether or Not They Are Silenced for Invariant Chain
Cancer Res., January 15, 2006; 66(2): 1147 - 1154.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
U. Kumaraguru, K. Banerjee, and B. T. Rouse
In vivo rescue of defective memory CD8+ T cells by cognate helper T cells
J. Leukoc. Biol., October 1, 2005; 78(4): 879 - 887.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. A. Kutzler, T. M. Robinson, M. A. Chattergoon, D. K. Choo, A. Y. Choo, P. Y. Choe, M. P. Ramanathan, R. Parkinson, S. Kudchodkar, Y. Tamura, et al.
Coimmunization with an Optimized IL-15 Plasmid Results in Enhanced Function and Longevity of CD8 T Cells That Are Partially Independent of CD4 T Cell Help
J. Immunol., July 1, 2005; 175(1): 112 - 123.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Timar, A. Ladanyi, C. Forster-Horvath, J. Lukits, B. Dome, E. Remenar, M. Godeny, M. Kasler, B. Bencsik, G. Repassy, et al.
Neoadjuvant Immunotherapy of Oral Squamous Cell Carcinoma Modulates Intratumoral CD4/CD8 Ratio and Tumor Microenvironment: A Multicenter Phase II Clinical Trial
J. Clin. Oncol., May 20, 2005; 23(15): 3421 - 3432.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. B. Villada, M. M. Barracco, M. Ziol, A. Chaboissier, N. Barget, S. Berville, B. Paniel, E. Jullian, T. Clerici, B. Maillere, et al.
Spontaneous Regression of Grade 3 Vulvar Intraepithelial Neoplasia Associated with Human Papillomavirus-16-Specific CD4+ and CD8+ T-Cell Responses
Cancer Res., December 1, 2004; 64(23): 8761 - 8766.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
G. R. Leggatt, S. Narayan, G. J. P. Fernando, and I. H. Frazer
Changes to peptide structure, not concentration, contribute to expansion of the lowest avidity cytotoxic T lymphocytes
J. Leukoc. Biol., October 1, 2004; 76(4): 787 - 795.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
E. C. Hsueh, E. Famatiga, S. Shu, X. Ye, and D. L. Morton
Peripheral Blood CD4+ T-Cell Response Before Postoperative Active Immunotherapy Correlates with Clinical Outcome in Metastatic Melanoma
Ann. Surg. Oncol., October 1, 2004; 11(10): 892 - 899.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Hiraoka, S. Yamamoto, S. Otsuru, S. Nakai, K. Tamai, R. Morishita, T. Ogihara, and Y. Kaneda
Enhanced Tumor-Specific Long-Term Immunity of Hemaggluttinating Virus of Japan-Mediated Dendritic Cell-Tumor Fused Cell Vaccination by Coadministration with CpG Oligodeoxynucleotides
J. Immunol., October 1, 2004; 173(7): 4297 - 4307.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Y. Chiang and I. Stroynowski
A Nonclassical MHC Class I Molecule Restricts CTL-Mediated Rejection of a Syngeneic Melanoma Tumor
J. Immunol., October 1, 2004; 173(7): 4394 - 4401.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Wong, R. Lau, J. Chang, T. Kuus-Reichel, V. Brichard, C. Bruck, and J. Weber
Immune Responses to a Class II Helper Peptide Epitope in Patients with Stage III/IV Resected Melanoma
Clin. Cancer Res., August 1, 2004; 10(15): 5004 - 5013.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Q. Chen, H. Jackson, P. Parente, T. Luke, M. Rizkalla, T. Y. Tai, H.-C. Zhu, N. A. Mifsud, N. Dimopoulos, K.-A. Masterman, et al.
Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant
PNAS, June 22, 2004; 101(25): 9363 - 9368.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. H. Slager, C. E. van der Minne, M. Kruse, D. D. Krueger, M. Griffioen, and S. Osanto
Identification of Multiple HLA-DR-Restricted Epitopes of the Tumor-Associated Antigen CAMEL by CD4+ Th1/Th2 Lymphocytes
J. Immunol., April 15, 2004; 172(8): 5095 - 5102.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Ruiz, H. Kobayashi, J. J. Lasarte, J. Prieto, F. Borras-Cuesta, E. Celis, and P. Sarobe
Identification and Characterization of a T-Helper Peptide from Carcinoembryonic Antigen
Clin. Cancer Res., April 15, 2004; 10(8): 2860 - 2867.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
X. S. Liu, Y. Xu, L. Hardy, V. Khammanivong, W. Zhao, G. J. P. Fernando, G. R. Leggatt, and I. H. Frazer
IL-10 Mediates Suppression of the CD8 T Cell IFN-{gamma} Response to a Novel Viral Epitope in a Primed Host
J. Immunol., November 1, 2003; 171(9): 4765 - 4772.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Nagorsen, C. Scheibenbogen, F. M. Marincola, A. Letsch, and U. Keilholz
Natural T Cell Immunity against Cancer
Clin. Cancer Res., October 1, 2003; 9(12): 4296 - 4303.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.